PTCB High-Yield Medication Safety Programs and REMS Guide
The iPLEDGE Program and Isotretinoin Safety
The iPLEDGE program is a highly regulated Risk Evaluation and Mitigation Strategy (REMS) specifically designed to manage the distribution and use of the medication isotretinoin. The primary purpose of this program is to prevent pregnancy exposure to isotretinoin, as the drug is known to cause severe and life-threatening birth defects. Due to these risks, the program mandates that everyone involved in the medication's supply chain and patient care cycle must be registered. This includes the patient, the prescriber, the pharmacy, and the wholesaler.
Strict dispensing requirements are a cornerstone of the iPLEDGE program. Patients must undergo regular pregnancy testing and adhere to specific windows for filling their prescriptions. For pharmacy technicians and students preparing for the PTCB exam, the "pearl" or key takeaway is that if a question asks which specific drug requires the iPLEDGE program, the answer is always Isotretinoin.
Isotretinoin is available under several brand names, and it is crucial to recognize both the generic and brand versions associated with this REMS program. The generic name is Isotretinoin. Historical and current brand names include Accutane (which is noted as a historical brand), Absorica, Amnesteem, Claravis, Myorisan, and Zenatane.
Risk Evaluation and Mitigation Strategies (REMS)
Risk Evaluation and Mitigation Strategies, commonly referred to by the acronym REMS, are safety programs mandated by the FDA for certain medications that carry serious, documented risks. These strategies are designed to ensure that the benefits of the drug outweigh its potential for harm. Beyond Isotretinoin, there are several other critical medications that require REMS monitoring to protect patient health.
Clozapine is a notable REMS medication that requires the monitoring of the Absolute Neutrophil Count (ANC). This is necessary because Clozapine carries a serious risk of severe neutropenia, a condition characterized by a dangerously low white blood cell count that can leave a patient vulnerable to life-threatening infections. Other prominent REMS medications include Lenalidomide, Thalidomide, and Pomalidomide. All three of these drugs are subject to REMS due to the high risk of severe birth defects associated with their use.
High-Alert Medications and Tall Man Lettering
High-alert medications are drugs that bear a heightened risk of causing significant patient harm when they are used in error. While the error rate for these medications may not be higher than others, the consequences of those errors are far more devastating. The list of high-alert medications includes Insulin, Heparin, Warfarin, Opioids, and various Chemotherapy agents.
To help prevent confusion between medications with similar-looking names (look-alike/sound-alike drugs), the practice of Tall Man Lettering is employed. This uses capitalized letters within a drug name to emphasize the differences between it and another similar name. Key examples identified for pharmacy safety include:
- hydrOXYzine versus hydrALAZINE
- DOBUTamine versus DOPamine
- vinBLAStine versus vinCRIStine
The Beers Criteria and Geriatric Medication Safety
The Beers Criteria is a list of medications that are generally considered potentially inappropriate for use in older adults. These drugs are often avoided in geriatric patients due to an increased risk of adverse effects or a lack of efficacy compared to alternatives. Common drugs found on the Beers Criteria list include:
- Diphenhydramine (brand name Benadryl)
- Hydroxyzine
- Amitriptyline
- Cyclobenzaprine
- Diazepam
- Lorazepam
- Alprazolam
- Zolpidem
- Meperidine
- Glyburide
- Promethazine
- High-dose Digoxin
NIOSH Hazardous Drugs and Black Box Warnings
The National Institute for Occupational Safety and Health (NIOSH) maintains a list of hazardous drugs that require special handling and the use of Personal Protective Equipment (PPE) to protect healthcare workers. Many chemotherapy drugs fall into this category. The risks associated with handling these hazardous drugs without proper precautions include the development of cancer, reproductive harm, and organ toxicity.
In addition to the handling risks, pharmacy staff must be aware of Black Box Warnings (BBW). A Black Box Warning is the strongest warning that the FDA requires and is used to alert healthcare providers and patients to serious or life-threatening risks associated with a medication.
PTCB Exam Memory Tips and Key Identifiers
For students preparing for the PTCB exam, the following high-yield associations should be committed to memory:
- Linking iPLEDGE exclusively to Isotretinoin.
- Identifying REMS as the general term for high-risk medication safety programs.
- Associating the Beers Criteria with medications that should often be avoided in the older adult population.
- Recognizing Black Box Warnings as the highest level of warning issued by the FDA.
- Classifying Insulin, Heparin, and Warfarin specifically as high-alert medications.